SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-012605
Filing Date
2018-09-17
Accepted
2018-09-17 06:07:00
Documents
1
Period of Report
2018-09-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k091718b_biondvax.htm 6-K 20803
  Complete submission text file 0001213900-18-012605.txt   21794
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 181072327
SIC: 2836 Biological Products, (No Diagnostic Substances)